MedTrace Logo

The Chinese STEMI PPCI Registry (CSPR)

NCT04996901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5594

Last updated 2021-12-20

No results posted yet for this study

Summary

The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.

Conditions

  • ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • The First College of Clinical Medical Science, China Three Gorges University

    collaborator UNKNOWN

  • The First Affiliated Hospital of Dalian Medical University

    collaborator OTHER

  • Jiangxi Provincial People's Hopital

    collaborator OTHER

  • The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture

    collaborator OTHER

  • Xiangyang No.1 People's Hospital

    collaborator OTHER

  • Wuhan Third Hospital

    collaborator OTHER

  • Renmin Hospital of Wuhan University

    lead OTHER

Principal Investigators

  • Liwei Cheng · Renmin Hospital of Wuhan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-22
Primary Completion
2021-12-05
Completion
2021-12-05

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04996901 on ClinicalTrials.gov